BLENDS / BLEND
GLOW BLEND
GHK-CU 35MG + TB-500 10MG + BPC-157 5MG · GHK-CU 50MG + TB-500 10MG + BPC-157 10MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A three-compound research blend combining GHK-Cu, TB-500 and BPC-157, studied for complementary tissue-repair and regenerative signalling pathways.
Available Strengths
- GHK-CU 35MG + TB-500 10MG + BPC-157 5MG (BBG50)
- GHK-CU 50MG + TB-500 10MG + BPC-157 10MG (BBG70)
Research Protocol
Reference daily schedule (combined blend dose)
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Weeks 1–4 | 2.33 mg | 10 | 0.1 mL |
Reconstitution
≈23.3 mg/mL total blend once reconstituted (≈16.43 mg/mL GHK-Cu, ≈3.43 mg/mL TB-500, ≈3.43 mg/mL BPC-157). Marked as a 'component' basis because this catalogue variant's strength label is a composite (multi-compound) string that the automated total-vial cross-check cannot parse — the 23.3 mg/mL figure has been manually verified as 70 mg ÷ 3.0 mL.
- Draw 3.0 mL of bacteriostatic water per 70 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved.
Research context
GHK-Cu is reported to act as a genomic modulator upregulating tissue-growth genes; TB-500 is reported to support cell migration and cytoskeletal remodelling; BPC-157 is reported to enhance growth-factor signalling and counteract inflammatory mediators.
Storage
−20°C or below for long-term stability. 2–8°C, use within 4 weeks; protect from light.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
- This is a proprietary multi-compound blend; no approved human protocol exists and there are major uncertainties around interactions, systemic exposure and long-term safety for the combined product.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source